Baker Tilly Wealth Management LLC Buys 91 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Baker Tilly Wealth Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,255 shares of the medical equipment provider’s stock after buying an additional 91 shares during the quarter. Baker Tilly Wealth Management LLC’s holdings in Intuitive Surgical were worth $655,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ISRG. Godsey & Gibb Inc. boosted its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth about $33,000. Mark Sheptoff Financial Planning LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at approximately $37,000. Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the third quarter valued at approximately $38,000. Finally, DT Investment Partners LLC raised its holdings in shares of Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.6 %

Shares of NASDAQ ISRG traded up $3.47 during trading hours on Friday, hitting $547.49. 469,607 shares of the stock were exchanged, compared to its average volume of 1,127,478. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $556.23. The firm has a fifty day moving average price of $535.11 and a 200-day moving average price of $493.61. The company has a market cap of $195.00 billion, a PE ratio of 88.02, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Mizuho upped their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Citigroup upped their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, BTIG Research lifted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.